Clinical Trial Update: Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections [NA]

View source ↗

Summary

This clinical trial compares 0.4% hyaluronic acid solution with hydroxyethylamide solution for submucosal injections during endoscopic resections of esophageal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms

Drugs mentioned

• Hyaluronic Acid (0.4% solution) (hyaluronic acid)
• Hydroxyethylamide (hydroxyethylamide)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Esophageal Neoplasms, Endoscopic Mucosal Resection | NA | Status: RECRUITING